However, more comprehensive studies are needed correlating the clinical outcome of PDAC patients with TMPRSS11B expression and to understand the role of TMPRSS11B as a prognostic marker in this tumor entity, as already performed in other cancer entities but with contrary findings. Here, TMPRSS11B is linked to cancer.